Du Y, Zhao Z, Yang C
Front Oncol. 2024; 14:1372481.
PMID: 38800377
PMC: 11116773.
DOI: 10.3389/fonc.2024.1372481.
Kraus D, Oettinger F, Kiefer J, Bannasch H, Stark G, Simunovic F
J Oncol. 2021; 2021:5580431.
PMID: 34007275
PMC: 8100420.
DOI: 10.1155/2021/5580431.
Dammerer D, Van Beeck A, Schneeweiss V, Schwabegger A
In Vivo. 2020; 34(6):3057-3068.
PMID: 33144410
PMC: 7811670.
DOI: 10.21873/invivo.12140.
Wong S, Quinn D, Bjarnason G, North S, Sridhar S
Am J Clin Oncol. 2020; 43(8):559-566.
PMID: 32398404
PMC: 7515769.
DOI: 10.1097/COC.0000000000000705.
Pennington Z, Ahmed A, Cottrill E, Westbroek E, Goodwin M, Sciubba D
Ann Transl Med. 2019; 7(10):225.
PMID: 31297390
PMC: 6595196.
DOI: 10.21037/atm.2019.01.59.
Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.
Erfanian Y, Grueneisen J, Kirchner J, Wetter A, Podleska L, Bauer S
Eur J Nucl Med Mol Imaging. 2017; 44(11):1823-1831.
PMID: 28567495
DOI: 10.1007/s00259-017-3736-y.
Comparison of MRI and PET-CT in detecting the loco-regional recurrence of soft tissue sarcomas during surveillance.
Park S, Chung H, Chae S, Lee J
Skeletal Radiol. 2016; 45(10):1375-84.
PMID: 27488833
DOI: 10.1007/s00256-016-2440-5.
Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.
Chang K, Kong C, Cho W, Jeon D, Lee S, Lim I
Skeletal Radiol. 2014; 44(4):529-37.
PMID: 25431093
DOI: 10.1007/s00256-014-2063-7.
Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.
Sharma P, Khangembam B, Sudhir Suman K, Singh H, Rastogi S, Khan S
Eur J Nucl Med Mol Imaging. 2013; 40(7):1036-43.
PMID: 23558689
DOI: 10.1007/s00259-013-2388-9.
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.
Costelloe C, Chuang H, Madewell J, Ueno N
J Cancer. 2010; 1:80-92.
PMID: 20842228
PMC: 2938069.
DOI: 10.7150/jca.1.80.
The role of multidetector CT arthrography in the investigation of suspected intra-articular hip pathology.
Christie-Large M, Tapp M, Theivendran K, James S
Br J Radiol. 2010; 83(994):861-7.
PMID: 20716653
PMC: 3473755.
DOI: 10.1259/bjr/76751715.
A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T.
Fayad L, Wang X, Salibi N, Barker P, Jacobs M, Machado A
AJR Am J Roentgenol. 2010; 195(1):W69-75.
PMID: 20566784
PMC: 3035623.
DOI: 10.2214/AJR.09.3718.
Post-operative imaging of soft tissue sarcomas.
James S, Davies A
Cancer Imaging. 2008; 8:8-18.
PMID: 18331968
PMC: 2267691.
DOI: 10.1102/1470-7330.2008.0003.
Imaging of pseudoneoplastic masses associated with allografts.
Kattapuram T, Ozhathil D, Hornicek F, Gebhardt M, Mankin H, Rosenberg A
Skeletal Radiol. 2007; 36(8):747-53.
PMID: 17415562
DOI: 10.1007/s00256-007-0292-8.
Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging.
Tateishi U, Yamaguchi U, Maeda T, Seki K, Terauchi T, Kawai A
Cancer Sci. 2006; 97(10):1125-8.
PMID: 16925579
PMC: 11158402.
DOI: 10.1111/j.1349-7006.2006.00288.x.
Giant-cell tumours of bone of the hand and wrist: a review of imaging findings and differential diagnoses.
James S, Davies A
Eur Radiol. 2005; 15(9):1855-66.
PMID: 15868123
DOI: 10.1007/s00330-005-2762-5.
Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
Schwarzbach M, Dimitrakopoulou-Strauss A, Willeke F, Hinz U, Strauss L, Zhang Y
Ann Surg. 2000; 231(3):380-6.
PMID: 10714631
PMC: 1421009.
DOI: 10.1097/00000658-200003000-00011.
MR imaging of edema accompanying benign and malignant bone tumors.
Kroon H, Bloem J, Holscher H, van der Woude H, Reijnierse M, Taminiau A
Skeletal Radiol. 1994; 23(4):261-9.
PMID: 8059251
DOI: 10.1007/BF02412359.
Intramuscular hypertrophic scar: an unusual complication following soft tissue sarcoma resection.
OConnell J, English J, Beauchamp C, Connell D
Skeletal Radiol. 1995; 24(4):305-7.
PMID: 7644948
DOI: 10.1007/BF00198422.
Non-neoplastic causes of high signal intensity at T2-weighted MR imaging after treatment for musculoskeletal neoplasm.
Panicek D, Schwartz L, Heelan R, Caravelli J
Skeletal Radiol. 1995; 24(3):185-90.
PMID: 7610410
DOI: 10.1007/BF00228920.